Aquaculture Vaccines Market to Reach USD 4.2 Bn by 2031 as mRNA and...

Aquaculture Vaccines Market to Reach USD 4.2 Bn by 2031 as mRNA and Oral Vaccines Replace Antibiotics

Posted 2025-04-17 13:14:18

311

[Hyderabad, April 17th, 2025] – The Aquaculture Vaccines Market, valued at 1.8 billion in 2023, will grow at 11.2% to 4.2 billion by 2031, as fish farms adopt advanced immunization, reports ClearView Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-aquaculture-vaccines-market/

2024 Industry Milestones

mRNA Breakthroughs

Elanco's water-delivered mRNA vaccine prevents 95% of TiLV cases.
RNAi-based shrimp vaccines enter commercial trials.

Needle-Free Revolution

PHARMAQ's oral vaccine survives digestive acids to trigger immunity.
Yeast-vectored vaccines provide 3x longer protection.

Climate Adaptation

Thermostable vaccines withstand 30°C without refrigeration.
Saline-tolerant formulations work across water types.

Regional Leaders

Europe (40%): Norway vaccinates 100% of farmed salmon.
Asia-Pacific (XX%): Vietnam's shrimp vaccine mandate.
Americas (XX%): Chile's USD 1B+ vaccinated salmon industry.

Executive Insights
"We're vaccinating fish more precisely than humans now – with mRNA and oral tech."
– Jeff Simmons, CEO, Elanco

Roadmap to 2031

2025: 50% of shrimp farms transition from antibiotics to vaccines.
2027: mRNA vaccines cover 30% of salmon production.
2030: Universal fish vaccines targeting multiple pathogens expected.

For more insights, visit https://clearviewmarketinsights.com/report-store

About ClearView Market Insights

ClearView Market Insights analyzes more than 80 animal health markets, spanning from livestock to aquaculture.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

Aquaculture_Vaccines_Market

Please log in to like, share and comment!